abrdn Healthcare Investors (NYSE:HQH – Get Free Report)’s stock price reached a new 52-week high on Monday . The stock traded as high as $23.15 and last traded at $23.0920, with a volume of 228437 shares changing hands. The stock had previously closed at $23.04.
abrdn Healthcare Investors Price Performance
The business has a 50-day moving average of $20.94 and a 200-day moving average of $19.80.
Institutional Investors Weigh In On abrdn Healthcare Investors
Institutional investors have recently made changes to their positions in the company. Concorde Asset Management LLC grew its holdings in abrdn Healthcare Investors by 6.3% during the 1st quarter. Concorde Asset Management LLC now owns 11,487 shares of the financial services provider’s stock worth $204,000 after acquiring an additional 676 shares in the last quarter. Ashton Thomas Securities LLC raised its stake in abrdn Healthcare Investors by 6.5% in the first quarter. Ashton Thomas Securities LLC now owns 11,592 shares of the financial services provider’s stock worth $206,000 after buying an additional 712 shares in the last quarter. Uhlmann Price Securities LLC lifted its holdings in abrdn Healthcare Investors by 3.0% during the first quarter. Uhlmann Price Securities LLC now owns 26,490 shares of the financial services provider’s stock worth $471,000 after buying an additional 779 shares during the period. Goldman Sachs Group Inc. lifted its holdings in abrdn Healthcare Investors by 7.2% during the first quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider’s stock worth $191,000 after buying an additional 788 shares during the period. Finally, NewEdge Advisors LLC boosted its position in abrdn Healthcare Investors by 2.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,130 shares of the financial services provider’s stock valued at $684,000 after acquiring an additional 897 shares in the last quarter. Institutional investors own 32.60% of the company’s stock.
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
- Five stocks we like better than abrdn Healthcare Investors
- Is Monster Beverage’s Best-Case Scenario Already Priced Into the Stock?
- Symbotic’s Q3 Profit Inflection Signals Underrated Growth Story
- Build Dividend Income at Low Cost With These ETFs
- 3 Major Earnings Winners You May Have Missed
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
